Our study’s key findings were that H19 significantly enhanced cardiac systolic performance in STZ-induced rats and that H19 administration decreased diabetes-induced myocardial fibrosis and cardiomyocyte death. The gene discussed is H19; the disease is Myocardial fibrosis.